Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79452-7 ◽

2009 ◽

Vol 2009 ◽

pp. 43-44

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Yearbook of Oncology ◽

10.1016/s1040-1741(10)79491-4 ◽

2010 ◽

Vol 2010 ◽

pp. 53-54

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

A phase II evaluation of pemetrexed (LY231514, IND #40061) in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: A study of the gynecologic oncology group

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5524 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5524-5524 ◽

Author(s):

D. S. Miller ◽

J. A. Blessing ◽

C. N. Krasner ◽

R. J. Mannel

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.02.019 ◽

2012 ◽

Vol 125 (2) ◽

pp. 367-371 ◽

Author(s):

Don S. Dizon ◽

John A. Blessing ◽

Richard T. Penson ◽

Richard D. Drake ◽

Joan L. Walker ◽

...

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.09.015 ◽

2005 ◽

Vol 96 (1) ◽

pp. 67-71 ◽

Author(s):

David Scott Miller ◽

John A. Blessing ◽

Steven Waggoner ◽

Jeanne Schilder ◽

Joel Sorosky ◽

...

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.06.009 ◽

2012 ◽

Vol 127 (1) ◽

pp. 70-74 ◽

Author(s):

Russell J. Schilder ◽

William E. Brady ◽

Heather A. Lankes ◽

James V. Fiorica ◽

Mark S. Shahin ◽

...

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.03.023 ◽

2012 ◽

Vol 125 (3) ◽

pp. 635-639 ◽

Author(s):

Michael A. Gold ◽

William E. Brady ◽

Heather A. Lankes ◽

Peter G. Rose ◽

Joseph L. Kelley ◽

...

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.12.018 ◽

2014 ◽

Vol 132 (3) ◽

pp. 526-530 ◽

Author(s):

Lainie P. Martin ◽

Michael Sill ◽

Mark S. Shahin ◽

Matthew Powell ◽

Paul DiSilvestro ◽

...

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.01.009 ◽

2008 ◽

Vol 109 (2) ◽

pp. 182-186 ◽

Author(s):

Susan C. Modesitt ◽

Michael Sill ◽

James S. Hoffman ◽

David P. Bender

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.10.022 ◽

2012 ◽

Vol 124 (3) ◽

pp. 569-574 ◽

Author(s):

Agustin A. Garcia ◽

Michael W. Sill ◽

Heather A. Lankes ◽

Andrew K. Godwin ◽

Robert S. Mannel ◽

...

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

Faculty Opinions recommendation of Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: an NRG oncology/gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726377012.793527326 ◽

2017 ◽

Author(s):

Katherine Fuh

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Randomized Phase Ii

Download Full-text